Elvira Munteis

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

The Present and Future of Monoclonal Antibody Therapies for Multiple Sclerosis.

The Present and Future of Monoclonal Antibody Therapies for Multiple Sclerosis.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Published: August 21, 2025

Ongoing phase 2 agents for multiple sclerosis: could we break the phase 3 trial deadlock?

Ongoing phase 2 agents for multiple sclerosis: could we break the phase 3 trial deadlock?

Journal: Expert opinion on investigational drugs

Published: February 25, 2025

Efficacy of cognitive rehabilitation in cognition and brain networks: A randomised clinical trial in patients with multiple sclerosis.

Efficacy of cognitive rehabilitation in cognition and brain networks: A randomised clinical trial in patients with multiple sclerosis.

Journal: NeuroImage. Clinical

Published: November 19, 2024

Decreased exercise-induced natural killer cell redistribution in multiple sclerosis.

Decreased exercise-induced natural killer cell redistribution in multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: January 04, 2024

Delayed B cell repopulation after rituximab treatment in multiple sclerosis patients with expanded adaptive natural killer cells.

Delayed B cell repopulation after rituximab treatment in multiple sclerosis patients with expanded adaptive natural killer cells.

Journal: European journal of neurology

Published: December 15, 2021

Dynamics and Predictors of Cognitive Impairment along the Disease Course in Multiple Sclerosis.

Dynamics and Predictors of Cognitive Impairment along the Disease Course in Multiple Sclerosis.

Journal: Journal of personalized medicine

Published: September 30, 2021

Impact of cytomegalovirus infection on B cell differentiation and cytokine production in multiple sclerosis.

Impact of cytomegalovirus infection on B cell differentiation and cytokine production in multiple sclerosis.

Journal: Journal of neuroinflammation

Published: March 19, 2020

Adaptive Features of Natural Killer Cells in Multiple Sclerosis.

Adaptive Features of Natural Killer Cells in Multiple Sclerosis.

Journal: Frontiers in immunology

Published: June 11, 2019

Th1Th17CM Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment.

Th1Th17CM Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment.

Journal: Mediators of inflammation

Published: October 31, 2018

Low cytomegalovirus seroprevalence in early multiple sclerosis: a case for the 'hygiene hypothesis'?

Low cytomegalovirus seroprevalence in early multiple sclerosis: a case for the 'hygiene hypothesis'?

Journal: European journal of neurology

Published: November 21, 2017

Predicting therapeutic response to fingolimod treatment in multiple sclerosis patients.

Predicting therapeutic response to fingolimod treatment in multiple sclerosis patients.

Journal: CNS neuroscience & therapeutics

Published: November 01, 2017

Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates.

Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: October 07, 2017

Showing 1-12 of 22

Last Updated: 09/26/2026